Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
Open Access
- 28 April 2020
- journal article
- review article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-15
Abstract
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron degeneration in adults, and several mechanisms underlying the disease pathology have been proposed. It has been shown that glia communicate with other cells by releasing extracellular vesicles containing proteins and nucleic acids, including microRNAs (miRNAs), which play a role in the post-transcriptional regulation of gene expression. Dysregulation of miRNAs is commonly observed in ALS patients, together with inflammation and an altered microglial phenotype. However, the role of miRNA-containing vesicles in microglia-to-neuron communication in the context of ALS has not been explored in depth. This review summarises the evidence for the presence of inflammation, pro-inflammatory microglia and dysregulated miRNAs in ALS, then explores how microglia may potentially be responsible for this miRNA dysregulation. The possibility of pro-inflammatory ALS microglia releasing miRNAs which may then enter neuronal cells to contribute to degeneration is also explored. Based on the literature reviewed here, microglia are a likely source of dysregulated miRNAs and potential mediators of neurodegenerative processes. Therefore, dysregulated miRNAs may be promising candidates for the development of therapeutic strategies.Keywords
Funding Information
- Motor Neurone Disease Association (Hafezparast/Apr15/836-791, Hafezparast/Apr18/861-791)
- Sussex Neuroscience PhD Programme
This publication has 232 references indexed in Scilit:
- Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegenerationJournal of Neuroinflammation, 2013
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain, Behavior, and Immunity, 2011
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Inflammation in ALS and SMA: Sorting out the good from the evilNeurobiology of Disease, 2010
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Extracellular mutant SOD1 induces microglial‐mediated motoneuron injuryGlia, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseasesActa Neuropathologica, 2008
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993